Will Uwe, Wegener Conrad, Graf Kai-Ivo, Wanzar Igor, Manger Thomas, Meyer Frank
Department of Gastroenterology, Municipal Hospital, Strasse des Friedens 122, D-07548 Gera, Germany.
World J Gastroenterol. 2006 Jul 14;12(26):4175-8. doi: 10.3748/wjg.v12.i26.4175.
Pancreatic pseudocysts (PPC) as a complication of pancreatitis are approached only in the case of abdominal pain, infection, bleeding, and compression onto the gastrointestinal tract or biliary tree.
From 02/01/2002 to 05/31/2004, all consecutive patients with symptomatic PPC who underwent an interventional endoscopic approach were evaluated in this pilot case-series study: Group (Gr.) I-Primary percutaneous (external), ultrasound-guided drainage. Gr. II-Primary EUS-guided cystogastrostomy. Gr. III-EUS-guided cystogastrostomy including intracystic necrosectomy.
(="follow up": n = 27): Gr. I (n = 9; 33.3%): No complaints (n = 3); change of an external into an internal drainage (n = 4); complications: (a) bleeding (n = 1) followed by 3 d at ICU, discharge after 40 d; (b) septic shock (n = 1) followed by ICU and several laparotomies for programmed lavage and necrosectomy, death after 74 d. Gr. II (n = 13; 48.1%): No complaints (n = 11); external drainage (n = 2); complications/problems out of the 13 cases: 2nd separate pseudocyst (n = 1) with external drainage (since no communication with primary internal drainage); infection of the residual cyst (n = 1) + following external drainage; spontaneous PPC perforation (n = 1) + following closure of the opening of the cystogastrostomy using clips and subsequently ICU for 2 d. Gr. III (n = 5; 18.5%): No complaints in all patients, in average two endoscopic procedures required (range, 2-6).
Interventional endoscopic management of pancreatic pseudocysts is a reasonable alternative treatment option with low invasiveness compared to surgery and an acceptable outcome with regard to the complication rate (11.1%) and mortality (3.7%), as shown by these initial study results.
胰腺假性囊肿(PPC)作为胰腺炎的一种并发症,仅在出现腹痛、感染、出血以及压迫胃肠道或胆道系统时才进行处理。
在这项前瞻性病例系列研究中,对2002年1月2日至2004年5月31日期间所有接受介入性内镜治疗的有症状PPC连续患者进行评估:第一组(I组)——初次经皮(外部)超声引导下引流。第二组(II组)——初次内镜超声引导下囊肿胃吻合术。第三组(III组)——内镜超声引导下囊肿胃吻合术,包括囊内坏死组织切除术。
(=随访:n = 27):I组(n = 9;33.3%):无不适(n = 3);外部引流转变为内部引流(n = 4);并发症:(a)出血(n = 1),在重症监护病房(ICU)治疗3天,40天后出院;(b)感染性休克(n = 1),随后入住ICU并进行多次剖腹手术以进行计划性灌洗和坏死组织切除术,74天后死亡。II组(n = 13;48.1%):无不适(n = 11);外部引流(n = 2);13例中的并发症/问题:第二个独立假性囊肿(n = 1)并进行外部引流(因为与初次内部引流无连通);残余囊肿感染(n = 1)+随后进行外部引流;PPC自发性穿孔(n = 1)+使用夹子封闭囊肿胃吻合口开口后,随后在ICU治疗2天。III组(n = 5;18.5%):所有患者均无不适,平均需要两次内镜操作(范围为2 - 6次)。
这些初步研究结果表明,与手术相比,胰腺假性囊肿的介入性内镜治疗是一种合理的替代治疗选择,具有低侵袭性,且并发症发生率(11.1%)和死亡率(3.7%)可接受。